• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

    4/5/24 4:09:50 PM ET
    $TRUP
    Medical Specialities
    Health Care
    Get the next $TRUP alert in real time by email
    SC 13G/A 1 tm2411195d1_sc13g.htm SC 13G/A

     

     

      

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 1)*

     

    Trupanion, Inc.
    (Name of Issuer)

     

    Common Stock, par value $0.00001 per share

    (Title of Class of Securities)
    898202106
    (CUSIP Number)

     

    March 26, 2024
    (Date of event which requires filing of this statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)
    xRule 13d-1(c)
    ¨Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 2 of 10

     

    1

    NAMES OF REPORTING PERSONS

     

    Ole Nielsen

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)   ¨

    (b)   ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Denmark

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH

    5

    SOLE VOTING POWER

     

    0 shares

    6

    SHARED VOTING POWER

     

    2,904,432 shares

    7

    SOLE DISPOSITIVE POWER

     

    0 shares

    8

    SHARED DISPOSITIVE POWER

     

    2,904,432 shares

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,904,432 shares

    10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES  ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    6.9%

    12

    TYPE OF REPORTING PERSON

     

    IN

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 3 of 10

     

    1

    NAMES OF REPORTING PERSONS

     

    NCMH ApS

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)   ¨

    (b)   ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Denmark

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH

    REPORTING
    PERSON WITH

    5

    SOLE VOTING POWER

     

    0 shares

    6

    SHARED VOTING POWER

     

    2,843,651 shares

    7

    SOLE DISPOSITIVE POWER

     

    0 shares

    8

    SHARED DISPOSITIVE POWER

     

    2,843,651 shares

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,843,651 shares

    10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES  ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    6.8%

    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 4 of 10

     

    1

    NAMES OF REPORTING PERSONS

     

    Nielsen Capital Management Fondsmæglerselskab A/S

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)   ¨

    (b)   ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Denmark

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH

    5

    SOLE VOTING POWER

     

    0 shares

    6

    SHARED VOTING POWER

     

    2,832,699 shares

    7

    SOLE DISPOSITIVE POWER

     

    0 shares

    8

    SHARED DISPOSITIVE POWER

     

    2,832,699 shares

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,832,699 shares

    10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES  ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    6.8%

    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 5 of 10

     

    1

    NAMES OF REPORTING PERSONS

     

    Kapitalforeningen Investin Pro – Nielsen Globale Aktier

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)   ¨

    (b)   ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Denmark

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH

    5

    SOLE VOTING POWER

     

    0 shares

    6

    SHARED VOTING POWER

     

    2,157,089 shares

    7

    SOLE DISPOSITIVE POWER

     

    0 shares

    8

    SHARED DISPOSITIVE POWER

     

    2,157,089 shares

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,157,089 shares

    10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES  ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    5.2%

    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 6 of 10

     

    Item 1(a).      Name of Issuer:

     

    Trupanion, Inc.

     

    Item 1(b).      Address of Issuer’s Principal Executive Offices:

     

    6100 4th Avenue S, Suite 200

    Seattle, Washington 98108.

     

    Item 2(a).      Name of Person Filing:

     

    Ole Nielsen, NCMH ApS (“NCMH”), Nielsen Capital Management Fondsmæglerselskab A/S (“NCMF”) and Kapitalforeningen Investin Pro – Nielsen Globale Aktier (“Investin”) (each, a “Reporting Person”)

     

    Item 2(b).      Address of Principal Business Office or, if None, Residence:

     

    For Ole Nielsen, NCMH and NCMF:

     

    Eriksholmvej 40

    4390 Vipperoed

    Denmark

     

    For Investin:

     

    Kapitalforeningen Investin Pro

    Kalvebod Brygge 1-3

    1780 Copenhagen V

    Denmark

     

    Item 2(c).      Citizenship:

     

    Ole Nielsen is a citizen of Denmark, and each of NCMH, NCMF and Investin is an entity organized under the laws of Denmark.

     

    Item 2(d).      Title of Class of Securities:

     

    Common stock, par value $0.00001 per share (the “Common Stock”).

     

    Item 2(e).      CUSIP Number:

     

    898202106

     

    Item 3.           If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

     

    Not applicable.

     

    Item 4.           Ownership.

     

    a)Amount beneficially owned: As of March 26, 2024, Ole Nielsen may be deemed to beneficially own 2,904,432 shares of Common Stock, comprised of (1) 1,550 shares held jointly by Mr. Nielsen and his spouse, (2) 10,952 shares held by NCMH, (3) 59,231 shares held by an entity of which Mr. Nielsen serves as CEO with investment and voting power over the securities held by the entity, (4) 2,157,089 shares held by Investin for which NCMF serves as advisor and (5) 675,610 shares held by various funds (other than Investin) for which NCMF serves as advisor.

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 7 of 10

     

    NCMF is an investment advisor based in Denmark and registered with the Danish Financial Supervisory Authority. NCMF furnishes investment advice to and manages certain investment funds, and Ole Nielson serves as CEO of NCMF. In its role as advisor, NCMF may be deemed the beneficial owner of (1) 2,157,089 shares held by Investin and (2) an aggregate of 675,610 shares of Common Stock held by funds other than Investin, in each case, as it may have or share voting and/or investment power with respect to such shares. Other than Investin, none of such funds individually holds more than 5% of the shares of Common Stock.

     

    NCMH owns 100% of NCMF, and Ole Nielsen indirectly owns 100% of NCMH. Mr. Nielsen also serves as CEO of NCMH. NCMH holds directly 10,952 shares of Common Stock and may also be deemed to beneficially own (1) the 2,157,089 shares held by Investin which is managed by NCMF and (2) an aggregate of 675,610 shares of Common Stock held by funds, other than Investin, managed by NCMF.

     

    Investin is a sub-fund in the umbrella fund Kapitalforeningen Investin Pro. Kapitalforeningen Investin Pro is an alternative investment fund and is registered with the Danish Financial Supervisory Authority. Investin holds directly 2,157,089 shares of Common Stock. NCMF serves as an advisor to Investin and has a discretionary fund management agreement with Investin, pursuant to which NCMF, at its discretion, can trade shares on behalf of Investin.

     

    Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership with respect to the shares of Common Stock reporting in this statement except to the extent that such Reporting Person has or shares voting or investment control with respect to such shares.

     

    b)Percent of Class: The percentages used in this Schedule 13G are calculated based upon 41,814,768 shares of Common Stock outstanding as of February 19, 2024, as reported in the issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2024. Therefore, as of March 26, 2024, Ole Nielsen may be deemed to beneficially own 6.9% of such outstanding shares, each of NCMF and NCMH may be deemed to beneficially own 6.8% of such outstanding shares and Investin may be deemed to beneficially own 5.2% of such outstanding shares.

     

    c)Number of shares as to which the person has:
       
    1)Sole power to vote or to direct the vote:
       
    ·Ole Nielsen – 0 shares
    ·NCMH – 0 shares
    ·NCMF – 0 shares
    ·Investin – 0 shares
       
    2)Shared power to vote or to direct the vote:
       
    ·Mr. Nielsen – 2,904,432 shares
    ·NCMH – 2,843,651 shares
    ·NCMF - 2,832,699 shares
    ·Investin – 2,157,089 shares

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 8 of 10

     

    3)Sole power to dispose or to direct the disposition of:
       
    ·Mr. Nielsen – 0 shares
    ·NCMH – 0 shares
    ·NCMF - 0 shares
    ·Investin – 0 shares
       
    4)Shared power to dispose or to direct the disposition of:
       
    ·Mr. Nielsen – 2,904,432 shares
    ·NCMH – 2,843,651 shares
    ·NCMF - 2,832,699 shares
    ·Investin – 2,157,089 shares

     

    Item 5.          Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.          Ownership of More Than Five Percent on Behalf of Another Person.

     

    The disclosure in Item 4(a) above is incorporated by reference into this Item 6.

     

    Item 7.          Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.          Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.          Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.        Certifications.

     

    Each of the undersigned Reporting Persons hereby makes the following certification:

     

    By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 9 of 10

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, each undersigned certifies that the information set forth in this statement is true, complete and correct.

     

     Dated: April 5, 2024  
       
       /s/ Ole Nielsen
      Ole Nielsen
       
       
      NCMH ApS
       
       
      By: /s/ Ole Nielsen
     

    Name:  Ole Nielsen

    Title:    CEO

       
       
      NIELSEN CAPITAL MANAGEMENT FONDSMÆGLERSELSKAB A/S
       
       
      By: /s/ Ole Nielsen
     

    Name:  Ole Nielsen

    Title:    CEO

       
       
      Kapitalforeningen Investin Pro – Nielsen Globale Aktier
       
       
      By:  /s/ Erling Skorstad
      Name:  Erling Skorstad
      Title:    Managing Director
       
       
      By:  /s/ Tage Fabrin-Brasted
      Name:  Tage Fabrin-Brasted
      Title:    Managing Director

     

     

     

     

     

    CUSIP No. 898202106 Schedule 13G Page 10 of 10

     

    EXHIBIT INDEX

     

    Exhibit Description of Exhibit
    99.2 Amended and Restated Joint Filing Agreement (filed herewith).

     

     

     

    Get the next $TRUP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRUP

    DatePrice TargetRatingAnalyst
    1/23/2025$57.00Neutral → Overweight
    Piper Sandler
    7/19/2024Outperform
    William Blair
    5/16/2024$35.00 → $49.00Neutral → Buy
    BofA Securities
    5/8/2023$72.00 → $32.00Buy → Neutral
    BofA Securities
    9/21/2022$77.00Buy
    Jefferies
    8/4/2022$80.00 → $69.00Overweight → Neutral
    Piper Sandler
    2/24/2022$129.00 → $118.00Neutral → Buy
    B of A Securities
    12/8/2021$126.00 → $183.00Overweight
    Piper Sandler
    More analyst ratings

    $TRUP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Top Animal Health Experts Address H5N1 Bird Flu in Trupanion Webinar

      SEATTLE, May 05, 2025 (GLOBE NEWSWIRE) -- Trupanion (NASDAQ:TRUP), the leading provider of medical insurance for dogs and cats, will host an upcoming webinar focused on the evolving state of bird flu (H5N1) and its impact on pets, pet parents, and the veterinary community. The complimentary one-hour RACE®-Approved CE webinar "Bird Flu: What We Know Now" will be available on-demand on petpublichealth.org/h5n1-update/ on Thursday, May 8th, at 11:00 AM PT / 2:00 PM ET. Hosted by Trupanion's Chief Veterinary/Product Officer, Dr. Steve Weinrauch, BVMS, MRCVS, the webinar features a panel of leading animal health experts, including: Gail Golab, PhD, DVM, MANZCVS (Animal Welfare), DACAW: Assoc

      5/5/25 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Reports First Quarter 2025 Results

      SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

      5/1/25 4:05:07 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Publishes 2024 Annual Letter to Shareholders

      SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, has published its 2024 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here. About Trupanion: Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the hig

      4/30/25 5:15:00 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4) (Amendment)

      4/A - TRUPANION, INC. (0001371285) (Issuer)

      5/15/24 7:27:19 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      5/9/24 6:40:58 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Leadership Updates

    Live Leadership Updates

    See more
    • Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

      Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits  SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B

      8/14/24 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion's Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024

      SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he

      5/2/24 4:04:29 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Appoints Richard Enthoven, Global Entrepreneur and Founder of Hollard Insurance Company Australia, as Independent Board Director

      A global entrepreneur with decades of experience growing insurance businesses worldwide, including pet insurance brands in Australia and South AfricaEnthoven associated with Tarmac DLTFM LTD., holder of 8.6% of Trupanion outstanding shares SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company's Board of Directors, effective today. Tarmac DLTFM LTD. ("Tarmac"), an Enthoven family investment entity, purchased shares of Trupanion in the open market between July and October of 2023, amounting to approximately 8.6% of Trupanion's outsta

      11/7/23 8:30:00 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Trupanion Inc.

      10-Q - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 5:20:35 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 4:02:29 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Trupanion Inc.

      DEFA14A - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 6:05:54 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Tooth Margaret sold $133,373 worth of shares (4,000 units at $33.34) and exercised 4,000 shares at a strike of $8.93 (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      4/23/25 4:19:30 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • CEO Tooth Margaret exercised 4,000 shares at a strike of $8.93 and sold $148,700 worth of shares (4,000 units at $37.17) (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      3/24/25 6:27:50 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Chief Administration Officer Mcgibney Brenna sold $164,926 worth of shares (5,000 units at $32.99), decreasing direct ownership by 57% to 3,738 units (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      3/11/25 4:20:06 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Trupanion Inc.

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      11/8/24 10:46:38 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      4/5/24 4:09:50 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      2/12/24 11:02:49 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Financials

    Live finance-specific insights

    See more
    • Trupanion Reports First Quarter 2025 Results

      SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

      5/1/25 4:05:07 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

      SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 first quarter after the market closes on Thursday, May 1, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can acce

      4/17/25 4:30:00 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Reports Fourth Quarter & Full Year 2024 Results

      SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2024. "2024 was a milestone year for Trupanion. Strong execution drove 20% subscription revenue growth, the doubling of our subscription margin in Q4 from its quarterly low in 2023, and a record $39 million in free cash flow," said Margi Tooth, Chief Executive Officer and President of Trupanion. "As we look to 2025, our focus remains on sustainable, measured growth while enhancing the member experience and improving retention." Fourth Quarter 2024 Financial and

      2/19/25 4:05:00 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Trupanion upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00

      1/23/25 7:55:01 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • William Blair initiated coverage on Trupanion

      William Blair initiated coverage of Trupanion with a rating of Outperform

      7/19/24 7:44:19 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion upgraded by BofA Securities with a new price target

      BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously

      5/16/24 7:37:42 AM ET
      $TRUP
      Medical Specialities
      Health Care